The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Endothelial Nitric Oxide Synthase in Vascular Disease: From Marvel to Menace
Abstract
Nitric oxide (NO·) is an important protective molecule in the vasculature, and endothelial NO· synthase (eNOS) is responsible for most of the vascular NO· produced. A functional eNOS oxidizes its substrate l -arginine to l -citrulline and NO·. This normal function of eNOS requires dimerization of the enzyme, the presence of the substrate l -arginine, and the essential cofactor (6 R )-5,6,7,8-tetrahydro- l -biopterin (BH 4 ), one of the most potent naturally occurring reducing agents. Cardiovascular risk factors such as hypertension, hypercholesterolemia, diabetes mellitus, or chronic smoking stimulate the production of reactive oxygen species in the vascular wall. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidases represent major sources of this reactive oxygen species and have been found upregulated and activated in animal models of hypertension, diabetes, and sedentary lifestyle and in patients with cardiovascular risk factors. Superoxide (O 2 · − ) reacts avidly with vascular NO· to form peroxynitrite (ONOO − ). The cofactor BH 4 is highly sensitive to oxidation by ONOO − . Diminished levels of BH 4 promote O 2 · − production by eNOS (referred to as eNOS uncoupling). This transformation of eNOS from a protective enzyme to a contributor to oxidative stress has been observed in several in vitro models, in animal models of cardiovascular diseases, and in patients with cardiovascular risk factors. In many cases, supplementation with BH 4 has been shown to correct eNOS dysfunction in animal models and patients. In addition, folic acid and infusions of vitamin C are able to restore eNOS functionality, most probably by enhancing BH 4 levels as well.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The uncoupling causes eNOS activity to change from healthy (producing NO) to toxic (generating superoxide) (303).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [303]
In the citing paper
“Similarly, vascular disease, cardiovascular disease (CVD), and metabolic syndrome all share effective loss of NO function[23,35–39].”
From Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health (2017) · cites this paper as [23]
Citations
Cites
NAD(P)H Oxidase: Role in Cardiovascular Biology and Disease
Griendling, K. K., Sorescu, D., & Ushio-Fukai, M. (2000) · Circulation Research · doi:10.1161/01.res.86.5.494 · Cited by 2,886
Rajagopalan, S., Kurz, S. D., Münzel, T. F., Tarpey, M. M., Freeman, B. Α., Griendling, K. K., & Harrison, D. G. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118623 · Cited by 2,466
Heitzer, T., Schlinzig, T., Krohn, K., Meinertz, T., & Münzel, T. (2001) · Circulation · doi:10.1161/hc4601.099485 · Cited by 1,961
Hypercholesterolemia increases endothelial superoxide anion production.
Ohara, Y., Peterson, T. E., & Harrison, D. G. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116491 · Cited by 1,765
Landmesser, U., Dikalov, S., Price, S. R., McCann, L., Fukai, T., Holland, S. M., Mitch, W. E., & Harrison, D. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200314172 · Cited by 1,660
Landmesser, U., Dikalov, S., Price, S. R., McCann, L. A., Fukai, T., Holland, S. M., Mitch, W. E., & Harrison, D. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci14172 · Cited by 1,652
Mechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus
Hink, U., Li, H., Mollnau, H., Oelze, M., Matheis, E., Hartmann, M., Skatchkov, M. P., Thaiss, F., Stahl, R. A. K., Warnholtz, A., et al. (2001) · Circulation Research · doi:10.1161/01.res.88.2.e14 · Cited by 1,190
Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions.
Förstermann, U., Closs, E. I., Pollock, J. S., Nakane, M., Schwarz, P., Gath, I., & Kleinert, H. (1994) · Hypertension · doi:10.1161/01.hyp.23.6.1121 · Cited by 1,110
Pollock, J. S., Förstermann, U., Mitchell, J. A., Warner, T. D., Schmidt, H. H. H. W., Nakane, M., & Murad, F. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10480 · Cited by 979
Ting, H. H., Timimi, F. K., Boles, K., Creager, S. J., Ganz, P., & Creager, M. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118394 · Cited by 869
Flagged first, then by citations
Research works printed but not linked: 23
- 10.1161/res.86.3.347 · DOI
- Li H Witte K August M Brausch I Gödtel-Armbrust U Habermeier A Closs EI Oelze M Münzel T Förstermann U. Reversal of eNOS uncoupling and upregulation of eNOS expression lowers blood pressure in hypertensive rats. J Am Coll Cardiol. In press.
- 10.1161/res.88.2.e14 · DOI
- 10.1161/circ.99.15.2027 · DOI
- 10.1161/res.86.5.494 · DOI
- 10.1161/circ.94.11.2756 · DOI
- 10.1161/circ.101.11.1261 · DOI
- 10.1161/circ.100.21.2131 · DOI
- 10.1161/hyp.30.1.57 · DOI
- 10.1161/res.77.3.510 · DOI
- 10.1161/circ.103.9.1282 · DOI
- 10.1161/hyp.33.6.1353 · DOI
- 10.1161/res.86.1.e7 · DOI
- 10.1161/res.86.2.e36 · DOI
- 10.1161/circ.104.10.1119 · DOI
- 10.1161/res.87.2.99 · DOI
- 10.1161/res.87.7.566 · DOI
- 10.1161/hyp.38.5.1044 · DOI
- 10.1161/circ.104.22.2673 · DOI
- 10.1161/circ.94.1.6 · DOI
- 10.1161/circ.97.3.237 · DOI
- 10.1161/atvb.22.1.6 · DOI
- 10.1161/atvb.20.1.185 · DOI
Cited by
Sorted by citations
Items 401–500 of 1,003
Mechanisms of Disease: L-arginine in coronary atherosclerosis—a clinical perspective
Tousoulis, D., Böger, R. H., Antoniades, C. A., Siasos, G., Stefanadi, E., & Stefanadis, C. (2007) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0878 · Cited by 72
“As the name indicates, the third key NOS isoform, eNOS, is expressed largely in endothelial cells”
BackgroundJoshi, M., Kotha, S. R., Malireddy, S., Selvaraju, V., Satoskar, A. R., Palesty, A., McFadden, D. W., Parinandi, N. L., & Maulik, N. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1861-x · Cited by 71
“Physiologically, nitric oxide plays a pivotal role in endothelium-dependent vasodilation and blood pressure regulation [77].”
BackgroundNitric oxide regulation of cellular metabolism: Adaptive tuning of cellular energy
Pappas, G., Wilkinson, M. L., & Gow, A. J. (2022) · Nitric Oxide · doi:10.1016/j.niox.2022.11.006 · Cited by 74
A novel mechanism of vascular relaxation induced by sodium nitroprusside in the isolated rat aorta
Bonaventura, D., Lunardi, C. N., Rodrigues, G. J., Neto, M. A., & Bendhack, L. M. (2008) · Nitric Oxide · doi:10.1016/j.niox.2008.02.004 · Cited by 73
Enkhjargal, B., Godo, S., Sawada, A., Nergui, S., Saito, H., Noda, K., Satoh, K., & Shimokawa, H. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303735 · Cited by 70
Oliveira‐Paula, G. H., Lacchini, R., & Tanus-Santos, J. E. (2016) · Nitric Oxide · doi:10.1016/j.niox.2016.08.004 · Cited by 72
l-Arginine transporters in cardiovascular disease: A novel therapeutic target
Chin-Dusting, J. P. F., Willems, L., & Kaye, D. M. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.08.001 · Cited by 69
Diabetic cardiomyopathy: An expression of stage B heart failure with preserved ejection fraction
Lam, C. S. (2015) · Diabetes and Vascular Disease Research · doi:10.1177/1479164115579006 · Cited by 69
Effects of diosgenin and its derivatives on atherosclerosis
Wu, F.-C., & Jiang, J. (2019) · Food & Function · doi:10.1039/c9fo00749k · Cited by 69
Chen, F., Kumar, S., Yu, Y., Aggarwal, S., Groß, C., Wang, Y., Chakraborty, T., Verin, A. D., Catravas, J. D., Lucas, R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099823 · Cited by 69
Bain, A. R., Weil, B. R., Diehl, K. J., Greiner, J. J., Stauffer, B. L., & DeSouza, C. A. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.08.001 · Cited by 71
Beyer, A., Durand, M. J., Hockenberry, J. C., Gamblin, T. C., Phillips, S. A., & Gutterman, D. D. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00557.2014 · Cited by 66
LDL receptors, caveolae and cholesterol in endothelial dysfunction: oxLDLs accomplices or victims?
Luchetti, F., Crinelli, R., Nasoni, M. G., Benedetti, S., Palma, F., Fraternale, A., & Iuliano, L. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15272 · Cited by 72
“…may occur as a consequence of an accelerated degradation of NO under oxidative stress conditions, that is, NO is transformed into peroxynitrite in the presence of superoxide anions or by a decreased endothelial NO synthase (eNOS) protein expression and/or activity (Förstermann & Münzel, 2006).”
BackgroundLi, H., Hortmann, M., Daiber, A., Oelze, M. W., Ostad, M. A., Schwarz, P. M., Xu, H., Xia, N., Kleschyov, A. L., Mang, C. F., et al. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.139030 · Cited by 67
“Thus, the NSAIDs are likely to produce oxidative stress and eNOS uncoupling similar to that observed in animal models of cardiovascular disease such as hypertension, hyperlipidemia, and diabetes mellitus (Förstermann and Münzel, 2006).”
BackgroundResultInfluentialProtective effects of AMP‐activated protein kinase in the cardiovascular system
Xu, Q., & Si, L. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01179.x · Cited by 68
Marques, B. C., Trindade, M., Aquino, J. C. F., Cunha, A. R., Gismondi, R. A., Neves, M. F., & Oigman, W. (2018) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2017.1288741 · Cited by 68
“Endothelial dysfunction is a phenomenon linking various cardiovascular risk factors for atherosclerosis such as dyslipidemia, hypertension, diabetes, and smoking (10).”
BackgroundBrunini, T. M. C., Mendes-Ribeiro, A., Ellory, J. C., & Mann, G. E. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.09.019 · Cited by 66
“Additionally, eNOS can promote superoxide production (eNOS uncoupling) under conditions of diminished availability of the substrate L-arginine or of the from https://academic.oup.com/cardiovascres/article-abstract/73/2/359/487 2018 essential cofactor tetrahydrobiopterin (BH4) [93].”
InfluentialExploiting the Pleiotropic Antioxidant Effects of Established Drugs in Cardiovascular Disease
Steven, S., Münzel, T. F., & Daiber, A. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160818185 · Cited by 68
“Uncoupling of endothelial nitric oxide synthase (eNOS) is a hallmark of most cardiovascular disease [10,11] and endothelial dysfunction in coronary and peripheral vessels, measured by acetylcholine-dependent plethysmography or flow-mediated”
BackgroundYamamoto, E., Kataoka, K., Dong, Y., Nakamura, T., Fukuda, M., Tokutomi, Y., Matsuba, S., Nako, H., Nakagata, N., Kaneko, T., et al. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.133884 · Cited by 66
Endothelial dysfunction and cardiometabolic diseases: Role of long non-coding RNAs
Sun, H., Hou, B., Wang, X., Zhu, X., Li, K., & Qiu, L.-Y. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.11.005 · Cited by 66
Kumar, G., Dey, S. K., & Kundu, S. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118377 · Cited by 71
Atherosclerosis: from biology to pharmacological treatment
Riccioni, G., & Sblendorio, V. T. (2012) · 老年心脏病学杂志:英文版 · doi:10.3724/sp.j.1263.2012.02132 · Cited by 71
Chen, X., Qian, S., Hoggatt, A. M., Tang, H., Hacker, T., Obukhov, A., Herring, P. B., & Seye, C. I. (2016) · Arteriosclerosis, Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.308561 · Cited by 59
“Decreased endothelial nitric oxide synthase (eNOS) activity and nitric oxide (NO) production are critical contributors to endothelial dysfunction (12).”
BackgroundCohen, G., Riahi, Y., Alpert, E., Gruzman, A., & Sasson, S. (2007) · Archives of Physiology and Biochemistry · doi:10.1080/13813450701783513 · Cited by 66
“Each of these compounds was tested in other studies and found to ameliorate oxidative stress-induced alterations in VEC (Bishara et al., 2002; Chen et al., 2006; Chen et al., 2007; Forstermann and Munzel, 2006; Hornig, 2002; Huwiler et al., 2001; Ji et al., 2003; Kowluru and Koppolu, 2002; Laurent et al., 2006; Lehr e…”
BackgroundNicotine induces endothelial dysfunction and promotes atherosclerosis via GTPCH 1
Li, J., Liu, S., Cao, G., Sun, Y., Chen, W., Dong, F., Xu, J., Zhang, C., & Zhang, W. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13812 · Cited by 65
“BH4 deficiency uncouples eNOS to generate superoxide rather than NO.(5) GTP cyclohydrolase 1 (GTPCH1) is the rate‐limiting enzyme in the de novo biosynthetic pathway of BH4.”
BackgroundInfluentialLi, J., Zhang, H., & Zhang, C. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.08.027 · Cited by 65
Ascorbic acid or l -arginine improves cutaneous microvascular function in chronic kidney disease
DuPont, J. J., Farquhar, W. B., Townsend, R. R., & Edwards, D. G. (2011) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00419.2011 · Cited by 65
“eNOS can be uncoupled by oxidation of BH4 (10) as well as competitive inhibition by ADMA (42), thus ascorbic acid and L-arginine may both have improved cutaneous vasodilation in the present study via a recoupling of eNOS.”
BackgroundAnthocyanins in chokeberry and purple maize attenuate diet-induced metabolic syndrome in rats
Bhaswant, M., Shafie, S. R., Mathai, M. L., Mouatt, P., & Brown, L. (2016) · Nutrition · doi:10.1016/j.nut.2016.12.009 · Cited by 70
El‐Mahdy, M. A., Ewees, M. G., Eid, M. S., Mahgoup, E. M., Khaleel, S. A., & Zweier, J. L. (2022) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00460.2021 · Cited by 69
Do patients benefit from omega-3 fatty acids?
Sherratt, S. C. R., Mason, R. P., Libby, P., Steg, P. G., & Bhatt, D. L. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad188 · Cited by 75
“192 Under normal conditions, eNOS catalyzes the formation of NO via coupling the oxidation of L -arginine with the reduction of molecular oxygen.”
BackgroundMatsumoto, S., Shimabukuro, M., Fukuda, D., Soeki, T., Yamakawa, K., Masuzaki, H., & Sata, M. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-30 · Cited by 66
Chronic obstructive pulmonary disease and atherosclerosis: common mechanisms and novel therapeutics
Brassington, K., Selemidis, S., Bozinovski, S., & Vlahos, R. (2022) · Clinical Science · doi:10.1042/cs20210835 · Cited by 72
Tang, Y., Scheef, E. A., Gürel, Z., Sorenson, C. M., Jefcoate, C. R. E., & Sheibani, N. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00153.2009 · Cited by 62
Up-regulation of A2B adenosine receptor in A2A adenosine receptor knockout mouse coronary artery
Teng, B., Ledent, C. A., & Mustafa, S. J. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.03.003 · Cited by 62
Cui, W., Zheng, Y., Zhang, Q., Wang, J., Wang, L., Yang, W., Guo, C., Gao, W., Wang, X., & Luo, D. (2014) · Laboratory Investigation · doi:10.1038/labinvest.2014.12 · Cited by 62
Macrophage Heterogeneity and Plasticity: Impact of Macrophage Biomarkers on Atherosclerosis
Rojas, J., Salazar, J. J., Martínez, M. S., Palmar, J., Bautista, J., Chávez-Castillo, M., Gómez, A., & Bermúdez, V. (2015) · Scientifica · doi:10.1155/2015/851252 · Cited by 65
“Data from our country reflect this global trend, with CVD being responsible for 20.9% of total mortality in Venezuela [3].”
BackgroundInfluentialLi, C., Zhang, W., Choi, J., & Frei, B. B. (2016) · Redox Biology · doi:10.1016/j.redox.2016.08.012 · Cited by 62
“ROS also exert pro-atherogenic effects by depleting NO and limiting its protective effects [12].”
BackgroundHyperglycemia-induced cardiac contractile dysfunction in the diabetic heart
Singh, R. M., Waqar, T., Howarth, F. C., Adeghate, E. A., Bidasee, K. R., & Singh, J. (2017) · Heart Failure Reviews · doi:10.1007/s10741-017-9663-y · Cited by 66
“Numerous mechanisms have been proposed to contribute to this clinical situation, including oxidative stress, microvascular abnormalities, and decreased sarcoplasmic reticular calcium uptake [20].”
BackgroundHypertension and Erectile Dysfunction: Breaking Down the Challenges
de Oliveira, A. A., & Nunes, K. P. (2020) · American Journal of Hypertension · doi:10.1093/ajh/hpaa143 · Cited by 64
Daiber, A., Oelze, M. W., Wenzel, P., Wickramanayake, J. M. D., Schuhmacher, S., Jansen, T., Lackner, K. J., Torzewski, M., & Münzel, T. F. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70005-2 · Cited by 62
“Endothelial dysfunction has been identified as a hallmark of most cardiovascular diseases [9], and it is always associated with vascular oxidative stress, decreased NO bioavailability, and/or impaired activity (uncoupling) of endothelial NO synthase [30, 61].”
BackgroundMitochondrial arginase II constrains endothelial NOS-3 activity
Lim, H. K., Lim, H. K., Ryoo, S., Benjo, A., Shuleri, K., Miriel, V. A., Baraban, E. G., Camara, A., Soucy, K. G., Nyhan, D. P., et al. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00700.2007 · Cited by 62
“This is consistent with the idea that it is the availability of substrate, cofactors, and dimerization that is more important than protein abundance with regard to NO production by the NOS-3 enzyme (8, 14, 24).”
BackgroundPeroxiredoxins as Potential Targets for Cardiovascular Disease
Jeong, S., Park, J., & Oh, G. T. (2021) · Antioxidants · doi:10.3390/antiox10081244 · Cited by 61
“Endothelial nitric oxide synthase (NOS)-derived NO controls the contraction of vascular smooth muscle cells through the regulation of soluble guanylyl cyclase and cyclic guanosine monophosphate and inhibits leukocyte adhesion and platelet aggregation [42].”
BackgroundLamoke, F., Mazzone, V., Persichini, T., Maraschi, A., Harris, M. B., Venema, R. C., Colasanti, M., Gliozzi, M., Muscoli, C., Bartoli, M., et al. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0304-x · Cited by 61
Tanahashi, K., Akazawa, N., Miyaki, A., Choi, Y., Ra, S., Matsubara, T., Kumagai, H., Oikawa, S., & Maeda, S. (2013) · American Journal of Hypertension · doi:10.1093/ajh/hpt217 · Cited by 61
Oxidative stress induces claudin-2 nitration in experimental type 1 diabetic nephropathy
Molina‐Jijón, E., Rodríguez‐Muñoz, R., Namorado, M. C., Pedraza‐Chaverrí, J., & Reyes, J. L. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.03.040 · Cited by 62
Attenuation of retinal vascular development and neovascularization in PECAM-1-deficient mice
DiMaio, T. A., Wang, S., Huang, Q., Scheef, E. A., Sorenson, C. M., & Sheibani, N. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2007.12.008 · Cited by 61
“The predominant NOS expressed in EC is eNOS, and it catalyzes the formation of NO from L-arginine, which results in the activation of soluble guanylyl cyclase and initiation of various signaling cascades with important roles in vascular homeostasis (Forstermann and Munzel, 2006).”
BackgroundLu, Z., Scott, I., Webster, B. R., & Sack, M. N. (2009) · Circulation Research · doi:10.1161/circresaha.109.204974 · Cited by 61
Yang, S., Liu, L., Meng, L., & Hu, X. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.10.006 · Cited by 61
Vasodilatory responsiveness to adenosine triphosphate in ageing humans
Kirby, B. S., Crecelius, A. R., Voyles, W. F., & Dinenno, F. A. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2010.197814 · Cited by 60
“Further, diminished endothelial function is observed in aged humans and has been closely related to oxidative stress (Taddei et al. 2001; Forstermann & Munzel, 2006; Ashfaq et al. 2008).”
BackgroundEndothelial Dysfunction in Heart Failure: What Is Its Role?
Drera, A., Rodella, L., Brangi, E., Riccardi, M., & Vizzardi, E. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13092534 · Cited by 68
“…levels oxidize intracellular macromolecules and lead to a reduction in the production of NO by inducing the formation of peroxynitrite [31], a cytotoxic oxidant that leads to degradation of the eNOS cofactor tetrahydrobiopterin [8], resulting in the “uncoupling” of eNOS and pro-oxidant activity.”
BackgroundHuang, C., Lin, A., Yang, T.-C., Liu, K., Chen, H., & Lii, C. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.12.005 · Cited by 60
Pharmacology and therapeutic role of inorganic nitrite and nitrate in vasodilatation
Bailey, J., Feelisch, M., Horowitz, J. D., Frenneaux, M. P., & Madhani, M. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.06.009 · Cited by 61
“…with a concomitant reduction in NO production occurs primarily when eNOS becomes monomeric (normally functional eNOS is a dimer) (Zou et al., 2004; Forstermann & Munzel, 2006) and dissociation and/or oxidation of the eNOS cofactor tetrahydrobiopterin has been suggested to play a key role in…”
Targeting NOS as a therapeutic approach for heart failure
Tang, L., Wang, H., & Ziolo, M. T. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.12.013 · Cited by 60
Koibuchi, N., Hasegawa, Y., Katayama, T., Toyama, K., Uekawa, K., Sueta, D., Kusaka, H., Ma, M., Nakagawa, T., Lin, B., et al. (2014) · Cardiovascular Diabetology · doi:10.1186/s12933-014-0157-0 · Cited by 61
Fan, Y., Zhang, R., Jiang, X., Wen, L., Wu, D., Liu, D., Yuan, P., Wang, Y., & Jing, Z. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt109 · Cited by 60
Pisarenko, O. I., Lankin, V. Z., Георгиевна, К. Г., Serebryakova, L. I., Шульженко, В. С., Timoshin, A. A., Tskitishvili, O. V., Pelogeykina, Y. A., & Studneva, I. M. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-2008-4 · Cited by 60
“The protective role of NO also includes the reduction of ROS production by neutrophils due to the inhibition of their adherence to vascular endothelia [39] .”
BackgroundKirsch, J., Schneider, H., Pagel, J.-I., Rehberg, M., Singer, M. S., Hellfritsch, J., Chillo, O., Schubert, K., Qiu, J., Pogoda, K., et al. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.307843 · Cited by 60
Long-chain monounsaturated fatty acids improve endothelial function with altering microbial flora
Tsutsumi, R., Yamasaki, Y., Takeo, J., Miyahara, H., Sebe, M., Bando, M., Tanba, Y., Izumi-Mishima, Y., Takeji, K., Ueshima, N., et al. (2021) · Translational research · doi:10.1016/j.trsl.2021.03.016 · Cited by 61
Tsigkou, V., Oikonomou, E. K., Anastasiou, A., Lampsas, S., Zakynthinos, G. Ε., Kalogeras, K. I., Katsioupa, M., Kapsali, M., Kourampi, I., Pesiridis, T., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054321 · Cited by 64
“, acetylcholine, arachidonic acid) [66].”
Saad, M. I., Abdelkhalek, T. M., Saleh, M. M., Kamel, M. A. E.-N., Youssef, M., Tawfik, S. H., & Domínguez, H. (2015) · Endocrine · doi:10.1007/s12020-015-0709-4 · Cited by 61
Won, J., Kim, J., Annamalai, B., Shunmugavel, A., Singh, I., & Singh, A. K. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121786 · Cited by 60
Omega-3 Polyunsaturated Fatty Acids: Structural and Functional Effects on the Vascular Wall
Zanetti, M., Grillo, A., Losurdo, P., Panizon, E., Mearelli, F., Cattin, L., Barazzoni, R., & Carretta, R. (2015) · BioMed Research International · doi:10.1155/2015/791978 · Cited by 59
“On the other hand, a number of studies have shown that reactive oxygen species (ROS), which are increased in many conditions associated with enhanced oxidative stress, determine endothelial dysfunction by quenching NO, reducing its bioavailability and leading to the formation of the highly toxic peroxynitrite [66, 67].”
BackgroundFukuda, M., Nakamura, T., Kataoka, K., Nako, H., Tokutomi, Y., Dong, Y., Ogawa, H., & Kim‐Mitsuyama, S. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e32833366cd · Cited by 59
Fu, J.-Y., Qian, L.-B., Zhu, L.-G., Liang, H.-T., Tan, Y., Lu, H., Lü, J., Wang, H., & Xia, Q. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.08.025 · Cited by 61
Hu, Q., Wu, D., Ma, F., Yang, S., Tan, B., Xin, H., Gu, X., Chen, X., Chen, S., Mao, Y., et al. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6607 · Cited by 59
“Both of them play a critical role in the cardiovascular system, including stimulation of angiogenesis, vasorelaxation, and improvement of ischemic heart diseases (16, 44, 50, 61).”
Allicin alleviates inflammation of diabetic macroangiopathy via the Nrf2 and NF-kB pathway
Li, C., Liu, X., Qiao, Y., Ning, L.-N., Li, W., Sun, Y.-S., Liu, D., Gao, W., & Ma, C. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173052 · Cited by 59
Ottolini, M., Daneva, Z., Chen, Y., Cope, E. L., Kasetti, R. B., Zode, G. S., & Sonkusare, S. K. (2020) · The Journal of Physiology · doi:10.1113/jp279570 · Cited by 59
“Additionally, many cardiovascular disorders have been associated with selective impairment of either eNOS-mediated or IK/SK channel-mediated vasodilatation (Forstermann & Munzel, 2006; Klinger et al. 2013; Ma et al. 2013; Sonkusare et al. 2014; Seki et al. 2017).”
BackgroundDaiber, A., Steven, S., Vujačić-Mirski, K., Kalinovic, S., Oelze, M. W., Lisa, F. D., & Münzel, T. F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103405 · Cited by 59
“They usually produce •NO by conversion of the substrate L-arginine to L-citrulline by electron transfer from NADPH and reaction of molecular oxygen with the help of the heme-iron and the cofactor tetrahydrobiopterin (BH4). ucNOS isoforms produce O2•¯ instead of •NO by electron transfer from NADPH to molecular oxygen,…”
BackgroundRegulation of NOS expression in vascular diseases
Pautz, A., Li, H., & Kleinert, H. (2021) · Frontiers in Bioscience-Landmark · doi:10.52586/4926 · Cited by 67
“As a result, ROS-induced ADMA-levels may reduce NOS3-mediated NO synthesis or even uncouple the enzyme [193].”
BackgroundArregi, A., Vegas, Ó., Lertxundi, A., Silva, A. I., Ferreira, I., Bereziartua, A., Cruz, M. T., & Lertxundi, N. (2024) · Environmental Science and Pollution Research · doi:10.1007/s11356-024-33973-9 · Cited by 77
“In noise-exposed mice, an increase in the expression of key enzymes involved in BH4 synthesis (GTP-cyclo-hydrolase-1 and dihydrofolate reductase) was noted.”
BackgroundInfluentialBosentan inhibits oxidative and nitrosative stress and rescues occlusive pulmonaryhypertension
Rafikova, O., Rafikov, R., Kumar, S., Sharma, S., Aggarwal, S., Schneider, F., Jonigk, D. D., Black, S. M., & Tofovic, S. P. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.09.013 · Cited by 58
Ong, P. K., Melchior, B., Martins, Y. C., Hofer, A., Orjuela-Sánchez, P., Cabrales, P., Zaniní, G. M., Frangos, J. A., & Carvalho, L. J. M. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003444 · Cited by 58
“Similarly, a concomitant augmentation of eNOS protein and NADPH oxidases, a major source of ROS, had been identified in many vascular diseases and is recognized as a potential mechanism that exacerbates their pathogenesis through enhancement of oxidative stress by eNOS uncoupling [36].”
BackgroundAscorbic Acid Reduces Noise‐Induced Nitric Oxide Production in the Guinea Pig Ear
Heinrich, U., Fischer, I., Brieger, J., Rümelin, A., Schmidtmann, I. M., Li, H., Mann, W. J., & Helling, K. (2008) · The Laryngoscope · doi:10.1097/mlg.0b013e31816381ae · Cited by 58
An, H., Wei, R., Ke, J., Yang, J., Liu, Y., Wang, X., Wang, G., & Hong, T. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.04.018 · Cited by 58
“This is an open access article u ormin attenuates fluctuating l of Diabetes and Its Complicati to L-citrulline and NO (Forstermann & Munzel, 2006).”
BackgroundKalinowski, L., Janaszak‐Jasiecka, A., Siekierzycka, A., Bartoszewska, S., Woźniak, M., Lejnowski, D., Collawn, J. F., & Bartoszewski, R. (2016) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-016-0017-x · Cited by 63
Krüppel-like factors in endothelial cell biology
Chang, E. B., Nayak, L. V., & Jain, M. K. (2017) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000337 · Cited by 58
Ferrochelatase is a therapeutic target for ocular neovascularization
Basavarajappa, H. D., Sulaiman, R. S., Qi, X., Shetty, T., Pasha, S. P. B. S., Sishtla, K. L., Lee, B., Quigley, J., Alkhairy, S., Briggs, C. M., et al. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201606561 · Cited by 58
Horke, S., Witte, I., Wilgenbus, P., Altenhöfer, S., Krüger, M., Li, H., & Förstermann, U. (2008) · Biochemical Journal · doi:10.1042/bj20080775 · Cited by 58
Plasma Tetrahydrobiopterin/Dihydrobiopterin Ratio A Possible Marker of Endothelial Dysfunction
Takeda, M., Yamashita, T., Shinohara, M., Sasaki, N., Takaya, T., Nakajima, K., Inoue, N., Masano, T., Tawa, H., Satomi‐Kobayashi, S., et al. (2009) · Circulation Journal · doi:10.1253/circj.cj-08-0850 · Cited by 58
Pietro, N. D., BALDASSARRE, M. P. A., Cichelli, A., Pandolfi, A., Formoso, G., & Pipino, C. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/6381380 · Cited by 57
On the epigenetics of vascular regulation and disease
Schleithoff, C., Voelter‐Mahlknecht, S., Dahmke, I. N., & Mahlknecht, U. (2012) · Clinical Epigenetics · doi:10.1186/1868-7083-4-7 · Cited by 59
“These small molecules exhibit opposing effects on the vascular tone and result in the production of potentially toxic substances, such as peroxynitrite (ONOO) [119-125].”
BackgroundBaumgardt, S. L., Paterson, M. R., Leucker, T. M., Fang, J., Zhang, D. X., Bosnjak, Z. J., Warltier, D. C., Kersten, J. R., & Ge, Z. (2016) · Circulation Heart Failure · doi:10.1161/circheartfailure.115.002424 · Cited by 57
Sánchez, A., Contreras, C., Martínez, M. P., Climent, B., Benedito, S., García‐Sacristán, A., Hernández, M., & Prieto, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036027 · Cited by 56
“Uncoupled eNOS generates superoxide instead of NO that continues to alter cell signalling processes in vascular endothelial and smooth muscle cells [35,36,37].”
BackgroundHyperuricemia and the Risk of Heart Failure: Pathophysiology and Therapeutic Implications
Si, K., Wei, C., Xu, L., Zhou, Y., Lv, W., Dong, B., Wang, Z., Huang, Y., Wang, Y., & Chen, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.770815 · Cited by 59
“org 3 radical, ONOO leads to lipid peroxidation and destroys endothelial membrane, accelerating the development of endothelial dysfunction (16).”
BackgroundAbdul‐Rahman, T., Dunham, A. J., Huang, H., Bukhari, S. M. A., Mehta, A., Awuah, W. A., Ede-Imafidon, D., Cantu‐Herrera, E., Talukder, S., Joshi, A. M., et al. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.101591 · Cited by 59
da Cunha, N. V., Pinge‐Filho, P., Panis, C., Silva, B. R., Pernomian, L., Grando, M. D., Cecchini, R., Bendhack, L. M., & Martins‐Pinge, M. C. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00520.2013 · Cited by 55
Jiang, X., Malkovskiy, A. V., Tian, W., Sung, Y. K., Sun, W., Hsu, J. L., Manickam, S., Wagh, D. A., Joubert, L., Semenza, G. L., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.09.092 · Cited by 56
Synergistic effects of colchicine combined with atorvastatin in rats with hyperlipidemia
Huang, C., Cen, C., Wang, C., Zhan, H., & Ding, X. (2014) · Lipids in Health and Disease · doi:10.1186/1476-511x-13-67 · Cited by 56
“Since NO could diminish oxidative stress and reduce ox-LDL production, which in turn leads to decrease foam cells formation and LpPLA2 excretion by macrophages and foam cells [29,32].”
BackgroundRodriguez‐Miguelez, P., Seigler, N., & Harris, R. A. (2016) · Journal of Visualized Experiments · doi:10.3791/54011 · Cited by 56
Loader, J., Méziat, C., Watts, R., Lorenzen, C. H., Sigaudo‐Roussel, D., Stewart, S., Reboul, C., Meyer, G., & Walther, G. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.308010 · Cited by 56
“12,13 However, due to a limited availability of microcirculatory data and discrepant reporting of macrovascular data, the impact of acute hyperglycemia on vascular function remains inconclusive and the underlying mechanisms not fully understood.”
BackgroundImprovement in endothelial function in cardiovascular disease - Is arginase the target?
Mahdi, A., Kövamees, O., & Pernow, J. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.11.004 · Cited by 59
Elbatreek, M. H., Sadegh, S., Anastasi, E., Güney, E., Nogales, C., Kacprowski, T., Hassan, A., Teubner, A., Huang, P., Hsu, C., et al. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000885 · Cited by 56
Genı́s, L., Gonzalo, P., Tutor, A. S., Gálvez, B. G., Martı́nez-Ruiz, A., Zaragoza, C., Lamas, S., Tryggvason, K., Apte, S., & Arroyo, A. G. (2007) · Blood · doi:10.1182/blood-2007-01-068080 · Cited by 56
“(2) the requirement for MT1-MMP in NO-”
BackgroundCircRNA–miRNA interactions in atherogenesis
Tong, K.-L., Tan, K., Lim, Y., Tien, X.-Y., & Wong, P. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04455-8 · Cited by 59
Domagała, T. B., Szeffler, A., Dobrucki, L. W., Dropiński, J., Polański, S., Leszczynska-Wiloch, M., Kotula-Horowitz, K., Wojciechowski, J., Wojnowski, L., Szczeklik, A., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.183210 · Cited by 55
“eNOS must be regarded as both an NO- and an O2 · -producing enzyme, and, therefore, eNOS may have a dual effect on vascular function, depending on its functional state.(7,10,11) Our results provide evidence that the direct action of MNA on the endothelium in the healthy normocholesterolemic and hypercholesterolemic su…”
BackgroundZhang, M., Song, P., Xu, J., & Zou, M. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.207712 · Cited by 57
Sheibani, L., Lechuga, T. J., Zhang, H., Hameed, A. B., Wing, D. A., Kumar, S., Rosenfeld, C. R., & Chen, D.-B. (2017) · Biology of Reproduction · doi:10.1095/biolreprod.116.143834 · Cited by 55
“With these samples we are able to repeat previously reported augmented NOS3 protein expression in human UA during estrogen-dominant physiological states [16].”
BackgroundInfluentialCeylan‐Isik, A. F., Guo, K. K., Carlson, E. C., Privratsky, J. R., Liao, S.-J., Cai, L. F., Chen, A. F., & Ren, J. T. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.123422 · Cited by 55
Endothelial Cell Regulation of Pulmonary Vascular Tone, Inflammation, and Coagulation
Goldenberg, N. M., & Kuebler, W. M. (2015) · Comprehensive physiology · doi:10.1002/cphy.c140024 · Cited by 63
Pojoga, L. H., Romero, J. R., Yao, T. M., Loutraris, P., Ricchiuti, V., Coutinho, P., Guo, C., Lapointe, N., Stone, J. R., Adler, G. K., et al. (2010) · Endocrinology · doi:10.1210/en.2009-0514 · Cited by 54
Metadata
- Authors
- Förstermann, U., & Münzel, T.
- Affiliations
- From the Departments of Pharmacology (U.F.) and Internal Medicine II (Cardiology) (T.M.), Johannes Gutenberg University Hospitals, Mainz, Germany.
- Venue
- Circulation
- Published
- 2006-04-04
- Volume
- 113
- Issue
- 13
- Pages
- 1708-1714
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2146190354
- Cited by
- 1,957
- References
- 67
- Citations by year
- 2026: 93 · 2025: 76 · 2024: 99 · 2023: 86 · 2022: 110 · 2021: 113 · 2020: 110 · 2019: 89 · 2018: 105 · 2017: 105 · 2016: 117 · 2015: 101 · 2014: 123 · 2013: 98 · 2012: 85
- FWCI
- 62.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- endothelial nitric oxide synthase, nitric oxide, tetrahydrobiopterin, eNOS uncoupling, NADPH oxidase, reactive oxygen species, superoxide, peroxynitrite, oxidative stress, cardiovascular risk factors, hypertension, hypercholesterolemia, diabetes mellitus, smoking, folic acid, vitamin C, L-arginine
- MeSH terms
- Animals, Endothelium, Vascular, Humans, Nitric Oxide, Vascular Diseases, Reactive Oxygen Species, Oxidative Stress, Nitric Oxide Synthase Type III
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review